Skip to main content

Decrease in New Cancer Diagnoses Seen in 2020

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 28, 2023 -- There was a decrease in new cancer diagnoses in 2020, according to a report published online Sept. 27 in Cancer.

Serban Negoita, M.D., Dr.P.H., from the National Cancer Institute in Bethesda, Maryland, and colleagues examined changes in the counts of U.S. incident cases by cancer type, age, sex, race, and disease stage in 2020 using data extracted from selected U.S. population-based cancer registries for diagnosis years 2015 to 2020. The monthly numbers of newly diagnosed cancer cases were extracted for colorectal, female breast, lung, pancreas, prostate, and thyroid cancer, and the ratio of observed-to-expected (O/E) incident cancer cases was calculated for 2020.

The authors found that for major screening-eligible cancer sites, the O/E ratio was <1.0, indicating fewer newly diagnosed cases than expected in 2020, with the lowest O/E ratios observed in April 2020. Asians/Pacific Islanders had the lowest O/E ratio for any race group for every cancer site except pancreas. Lower O/E ratios were seen for cases diagnosed at localized versus advanced stages.

"These missed opportunities for early cancer detection are alarming, particularly for those vulnerable populations that continue to face significant barriers in accessing cancer care," Monica M. Bertagnolli, M.D., director of the National Cancer Institute, said in a statement. "This report highlights the urgency in helping all Americans get back on track with their cancer care so that we can avoid unnecessary deaths and complications from cancer."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted September 2023

Read this next

Mortality in Rheumatic Heart Disease Is High

FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer

FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.